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Mathematical Analysis of ALS Biochemistry 
by Emily Rose Bainwol 
Abstract 
The purpose of this research is to further characterize the apoptotic pathways involved in 
a neuron affected by familial ALS. ALS is an aggressive disease that affects many people 
presently. However, research on neurodegeneration as it specifically pertains to ALS is limited 
because research on more common neurodegenerative diseases takes priority. The main objective 
of this research is to create a greater understanding of some of the major defining features of 
ALS - including mutated SOD1 gene, excitotoxicity, and organelle dysfunction. The hope is that 
this will help current research on the disease develop more effective treatments and, eventually, 
possibly even a cure. 
Copper-Zinc Superoxide Dismutase (SOD1) codes for an enzyme critical for breakdown 
of metabolic waste – specifically reactive oxygen species such as hydrogen peroxide. Mutated 
forms of SOD1 lead to accumulated waste in the cells. This contributes to the development of 
other apoptotic factors – including apoptosome formation – within the cell. With this project, the 
combined effects of this waste accumulation and other outcomes of mutated SOD1 will be 
investigated. The ultimate goal is to identify how those effects lead to increased risk for ALS 
onset. 
The current clinical literature on ALS has been researched in order to identify and 
explore a number of mutations at the SOD1 gene that are linked to the disease. The relevant 
literature is used to create a biochemical model of SOD1 processes and all of the involved 
chemical species using a freeware program, Cell Designer. The data will be quantitatively 
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analyzed by creating a mathematical model of the biochemical model. With this mathematical 
model, it will be easier to identify which ones play important roles in ALS onset and progression. 
1. Introduction  
Amyotrophic Lateral Sclerosis (ALS) is a neurological disease in which degeneration of 
motor neurons leads to muscle atrophy. Several factors contribute to ALS onset, making it 
difficult to determine initial trigger points. These factors include reactive oxygen and nitrogen 
species, excitotoxicity, organelle dysfunction and mutation of the SOD1 gene. This study uses 
biochemical systems theory (BST) to analyze a model displaying the major biochemical 
pathways that occur within a neuron subject to the effects of ALS. The model mainly emphasizes 
effects of mSOD1 and organelle dysfunction, as well as the pathways affected downstream, on 
neuronal cell death.  
BST was created by Savageau (1969) and modified in our research group by Sass et al. 
(2009). This program utilizes system equations to create a mathematical framework of a 
biochemical system (in this case, within a neuron). The mathematical framework helps determine 
both the individual and overall effects of reactions that take place within the neuron. BST is 
extremely useful when previously conducted experiments do not provide sufficient information 
about species concentrations (and their effects within the cell) or when current experimental 
studies are unable to do so.  
In this study, BST was used to evaluate different states of an ALS-affected neuron. First, a 
baseline ALS state was created in which all reactions were assigned arbitrary, relative numerical 
values. Certain ALS trigger points within the biochemical pathways were located and their 
mathematical values increased to mimic the disease state in the neuron. Various treatment states 
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were created. These created decreased mathematical values of the different combinations of 
processes that lead to the disease state, such as aggregation of mSOD1 protein. The results of the 
data from the treatment states in comparison to the data from the disease state could potentially 
yield useful insight for future experimental studies on ALS. 
Please refer to earlier work from our lab using the same approach to model and evaluate 
neurodegenerative diseases (Sass et al., 2009; Yeager & Coleman, 2010; Broome & Coleman, 
2011).  
2. Methods 
Cell Designer (Funahashi et al., 2003) was used to create a visual model of the biochemical 
pathways, which were then assigned mathematical parameters and entered into the Power Law 
Analysis and Simulation (PLAS) program (http://www.dqb.fc.ul.pt/docentes/aferreira/plas.html), 
to allow mathematical analysis (Kitano et al., 2005). This section presents major pathways 
included in the ALS model. 
2.1 Modeled pathways 
2.1.1 Aggregation of mutated SOD1 protein 
The accumulation of mutated SOD1 protein is the first step shown in the model, and it 
leads to the alteration of many other cellular pathways both directly and indirectly. All of the 
pathways involving mSOD1 aggregation eventually result in apoptosis of the neuron. One of 
these pathways is the exiting of cytochrome c from the mitochondria. This causes the activation 
of caspase-9, which then catalyzes a series of reactions that eventually result in apoptosis (Slee et 
al., 1999). Mutated SOD1 contributes to this pathway by catalyzing the activation of CHOP 
protein in the endoplasmic reticulum (Soo et al., 2012). CHOP then works with Bim protein in 
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the ER to catalyze the translocation of phosphorylated Bax to the mitochondria, where it forms 
the MAC channel. This channel catalyzes the transport of cytochrome c out of the mitochondria 
and into the cytoplasm (Jiang et al., 2011; Laurent et al., 2006; Slee et al., 1999; Soo et al., 
2012). Refer to Model 1 for a more comprehensive view of this process. This is one of several 
outcomes discussed in this paper for the involvement of mSOD1 in neuronal apoptosis. 
2.1.2 Formation of reactive oxygen and nitrogen species 
Reactive oxygen and nitrogen species that are produced in a neuron affected by ALS are 
a major cause of apoptosis. The formation of hydroxyl radical from hydrogen peroxide, 
catalyzed by iron in the lysosome, results in the activation of protein kinase A (PKA) (Jiang et 
al., 2011; Li et al., 2011; Shkolnik et al., 2011). PKA activates NF Kappa-Beta, a eukaryotic 
transcription factor for the Fas ligand (see Model 2 and section 2.1.9) (Bilak et al., 2004; Beckers 
et al., 1989, Kasibhatla et al., 1998, Parry et al., 1997; Wajant, 2002). Activation of this protein 
is also catalyzed by the formation of superoxide anion and peroxynitrite (Shkolnik et al., 2011). 
Activation of NADPH Oxidase in the lysosome leads to superoxide anion formation (also in the 
lysosome) (Boillée et al., 2008; Harraz et al., 2008). This then results in the accumulation of 
peroxynitrite in the neuron (Szabó, 1996). 
2.1.3 Caspase activation 
The activation of caspases 1,2,3,8, and 9 all trigger the activation of multiple cell 
processes that result in neuronal apoptosis. Caspase-1 catalyzes the activation of interleukin 1-
beta (Birell et al., 2011; Meissner et al., 2010). This in turn activates COX-2 gene transcription 
(Cheng et al., 2000; Consilvio et al., 2004). COX-2 protein then catalyzes the first step in the 
arachidonic acid cascade, in which arachidonic acid is converted to the prostaglandin 
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endoperoxide PGG2. The result of this cascade is Ca
2+
 influx (Li et al., 2011; Sureda, 2000), 
which accumulates in the cell, leading to apoptosis (see 2.1.4). A similar cascade of events 
results in the activation of caspase-9, which is cleaved from its inactive form by the apoptosome 
that forms as a result of cytochrome c exiting the mitochondria. See Model 3 for a more 
complete representation of this caspase cascade. 
2.1.4 Ca2+ accumulation 
Ca
2+
 accumulation in the endoplasmic reticulum, mitochondria, and cytosol is a major 
contributor to neuronal apoptosis.  The buildup of Ca
2+
 catalyzes many reactions, including those 
that result in the dysfunction of the ER and mitochondria. Reactions of importance to this study 
that are catalyzed by Ca
2+
 and occur in the cytosol include activation of nitric oxide synthase and 
of phospholipase A2 (Jiang et al., 2011; Liñares et al., 2006). NO synthase activation creates a 
buildup of nitric oxide, leading to peroxynitrite buildup, which is toxic to the cell (Szabó, 1996; 
Liñares et al., 2006). Phospholipase A2 (activated by cytosolic Ca
2+
) catalyzes the arachidonic 
cascade (Jiang et al., 2011). Products of this cascade trigger reactions downstream resulting in 
apoptosis. All of the reactions catalyzed by intracellular Ca
2+
 in this study (e.g. Fas signaling and 
ER dysfunction) eventually lead to apoptosis (see Model 2). 
2.1.5 Golgi dysfunction 
Golgi dysfunction initiates with the translocation of caspase-2 to the Golgi apparatus, 
where it catalyzes cleavage of Golgin 160 (Jiang et al., 2011). Golgins play a role in membrane 
structure and stability, which are at risk when golgins lose their function via cleavage (Barr & 
Short, 2003). When cleaved, Golgin 160 is a main contributing factor to Golgi dysfunction. 
Caspase-3, caspase-7, and ER stress also contribute to Golgin 160 cleavage (Hicks & Machamer, 
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2005). Another trigger point for Golgi dysfunction is the buildup of mixed lineage kinase-3 
(MLK3) in the cytoplasm (Cha et al., 2004). MLK3 is responsible for phosphorylation of Golgin 
160, which leads to excess cleavage.  
Additionally, cleavage of other proteins within the Golgi inhibits their normal function 
and also leads to Golgi dysfunction. One such protein is the transport factor p115, which is 
involved in ER-Golgi traffic (Barr, 1999). When normally functioning, P115 forms a complex 
with GRASP65, GM140, and Giantin (Hicks & Machamer, 2005). This complex aids in correct 
targeting of proteins to the Golgi. When p115 is cleaved, it is not available for complex 
formation and Golgi dysfunction results from disrupted protein transport (see Model 4). 
2.1.6 Endoplasmic reticulum dysfunction 
ER dysfunction in ALS is closely tied to mSOD1 aggregation. Toxic mSOD1 builds up 
in the cytoplasm and reaches the ER lumen (Soo et al., 2012). This, together with Bim inside the 
ER, leads to ER stress (Soo et al., 2012). Stress to the ER is directly linked to ER dysfunction.  
Additionally, mSOD1 in the ER activates CHOP. Active CHOP enhances Bax translocation to 
the mitochondria, eventually leading to apoptosome formation (Gotoh et al., 2004; Kim et al., 
2006) (see Model 1). 
Null Hong Kong mutant protein (NHK) inside the ER promotes ER stress and therefore 
ER Dysfunction (Nishitoh et al., 2008). Ubiquitination of NHK prevents this. When mSOD1 is 
present, it joins with Derlin1 to form a complex. This complex inhibits ubiquitination of NHK. In 
this way, mSOD1 inhibits inhibition of ER stress (see Model 5).  
2.1.7 Mitochondrial dysfunction 
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Mitochondrial dysfunction is closely tied to ER dysfunction via CHOP and calcium 
buildup. Dysfunction within the mitochondria results mainly from calcium buildup and caspase 
activation. Calcium translocates from the ER to the mitochondria, where it contributes to 
mitochondrial dysfunction (Kuwana et al., 2003). Caspase-3 and caspase-8 both contribute to 
mitochondrial dysfunction as well (Li et al., 1998) (see Model 6). Mutated SOD1 plays a role as 
well, as it enhances translocation of cytochrome c out of the mitochondria and into the cytoplasm 
(Takeuchi et al., 2002), as shown in Model 6. In the cytoplasm, cytochrome c forms the 
apoptosome with Apoptotic protease activating factor 1 (APAF 1) and activates the caspase 
cascade. Caspase-3 and caspase-8 are then available to further inhibit normal mitochondrial 
function. 
2.1.8 Glutamate excitotoxicity 
Calcium buildup contributes largely to glutamate excitotoxicity. Calcium buildup in the 
astrocyte aids in activation of the arachidonic acid cascade, eventually leading to PGE2 
formation in the astrocyte (Consilvio et al., 2004; Jiang et al., 2011). PGE2 then promotes 
glutamate exiting the astrocyte into the synapse. The postsynaptic neuron picks up the excess 
glutamate.  Once in the neuron, glutamate activates NF-KappaB, which initiates Fas signaling 
via FasL transcription (Wajant, 2002) (see 2.1.9 and Model 2). Glutamate toxicity also promotes 
toxic mSOD1 buildup and formation of reactive nitrogen species (Harraz et al., 2008; Szabó, 
1996). The peroxynitrite that results also contributes to FasL transcription by activating PKA 
(see 2.1.2 and Model 2). Refer to Model 7 for a schematic overview of the effects of glutamate 
toxicity. 
2.1.9 Fas signaling 
8 
 
Fas ligand binds to its receptor and forms a complex. This complex promotes 
accumulation of reactive oxygen species, thus contributing to apoptosis (Cheng et al., 2010; 
Vercammen et al., 1998). Fas and Fas ligand then form the death-inducing signaling complex 
(DISC), where they are joined with Fas-Associated protein with Death Domain (FADD) 
(Wajant, 2002). FADD is an adaptor molecule that bridges Fas-receptor and other death 
receptors to caspase-8, which is also a component of DISC (see Model 2). DISC promotes 
activation of caspase-8, which leads to mitochondrial dysfunction and p115 cleavage (see 2.1.5 
and 2.1.7). Therefore DISC plays a large role in organelle dysfunction. 
2.2 PLAS 
The Power Law Analysis and Stimulation (PLAS) program uses mathematical equations to 
predict changes in concentrations of species of interest over time. Each pathway in the model 
was assigned a numerical value. Each of the n species involved was assigned a variable (X1 – 
Xn).  
2.2.1. Initial variables 
Each chemical species (e.g. protein, enzyme, ion) was assigned an X-value. Species that were 
not affected by any other species (regardless of whether or not they had an effect on other 
species) were labeled as independent, whereas those that were affected by at least one other 
species were labeled as dependent. Initial concentrations were given to each X-value. These 
concentrations were based on the species’ assumed relative concentrations, which were 
estimated from the data provided by the literature. More details regarding PLAS can be found in 
previous reports from our lab (Sass et al., 2009). 
2.2.2. System equations 
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Each X-value was used to create a system equation. Numerical J-values were assigned to 
each reaction in the biochemical model in order to identify them. J-values were then added to or 
subtracted from each system equation. J values leading to the formation of species X are positive 
and those leading away from X are negative. For example, amyloid-beta protein is formed from 
degraded amyloid-beta protein precursor (APP) (J2) and amyloid-beta aggregate is accumulated 
from amyloid-beta (J3). Thus the system equation for amyloid-beta (X4) is X4’= J2 – J3.  
2.2.3. Flux Equations 
A rate constant, k, was assigned to each process in the baseline state. The k values vary based 
on the rates of reactivity for each reaction. For example, accumulation of mSOD1 in the 
mitochondria (J81) is due to the presence of toxic cytoplasmic mSOD1 (X8). The flux equation 
for mitochondrial mSOD1 accumulation is J81 = k81 X8^g818, with k81 and g818 as rate-
determining constants. These constants are generally left as 1.00. Species that act as catalysts for 
the reactions (promote formation of X) are positive and given a rate constant p (promoting). 
Those that inhibit the reactions are negative and given a rate constant i (inhibiting). P-values are 
usually left as 1.00 and i-values are usually left as -1.00. For example, formation of caspase-9 
(J26) from procaspase-9 (X32) is catalyzed by the Apaf 1 – cytochrome c complex (X28) (see 
3.1.1) and inhibited by XIAP protein (X76). The flux equation for this reaction is J26 = k26 
X32^g2632. The value for k26 in the baseline state is .01, and the rate, which initially remains 
small for baseline conditions, is given by k’ = .0001*(p2628 X28 + i2676 X76).  
2.2.4. Excel Spreadsheets 
For each X-value, PLAS determines concentrations over a pre-determined time interval. The 
data output in table form was copied into an Excel spreadsheet in order more easily manipulate a 
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graphical analysis of the data. This was done for the baseline state, disease state, and treatment 
state for each X-value chosen. The formula used for the disease state graphs was (disease-
baseline)/baseline in order to evaluate the concentration changes as a percentage of certain X-
values from baseline state to disease state. Similarly, the formula used for the treatment state 
graphs was (treatment-disease)/disease to evaluate percent change in concentrations from disease 
state to treatment state. This allowed for a better visual interpretation of the data by showing the 
trends certain X-values had in any given state. 
3. Results 
3.1 Apoptotic levels 
3.1.1 Disease model 
The rate of apoptosis increases dramatically with the increase of cytosolic Ca
2+
. Ca
2+
 in 
the cytosol of the neuron contributes to buildup of stress to the endoplasmic reticulum (Jiang et 
al., 2011; Soo et al., 2012), which results in mSOD1 aggregation. The increased activation and 
accumulation of apoptotic factors (including mSOD1) and other cellular abnormalities (such as 
those described in 3.3 – 3.5) also contributed to the greater rate of apoptosis in the disease model.  
Bax translocation from the cytosol to the mitochondria is a large contributor to increased 
apoptotic levels (Kim et al., 2006). Once in the mitochondria, phosphorylated Bax joins with Bak 
to form the mitochondrial apoptosis-induced channel (MAC), which catalyzes the release of 
Cytochrome c into the cytosol. Cytochrome c then joins with Apaf 1 to form the apoptosome, 
which triggers the caspase cascade via activation of caspase-9 (see Models 1 and 3). 
Refer to Figure 1 for comparison of apoptotic levels between disease and treatment states. 
3.1.2 Treatment model 
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The treatment model that resulted in the greatest decline of the major processes 
contributing to apoptosis (see 3.2-3.5) was created by implementing a cocktail of four 
pharmaceutical drugs. These drugs have been previously tested and used individually, but not in 
combination. Minocycline activity was included in the cocktail as an inhibitor of cytochrome c 
release to the cytosol (Zhu et al., 2002). The decrease in apoptotic levels was enhanced with the 
administration of this drug alone, confirming its validity as a treatment. Inhibitors of IP3 
activation (XC, 2-ABP, and NSAID) decreased apoptotic levels by indirectly inhibiting Ca
2+ 
influx in the cytoplasm (Birrell et al., 2011; Li et al., 2011). While Minocycline was more 
effective at attenuating apoptotic levels, the cocktail of all four drugs was 1.5 times as effective 
(see Figure 1).  
3.2 Peroxynitrite  
3.2.1 Disease model 
Peroxynitrite levels in the disease state sufficiently increase due to increased activation of 
nitric oxide synthase, which is catalyzed by increased cytosolic Ca
2+
 levels (see Model 2). 
Increased peroxynitrite levels then trigger other pathways that result in apoptosis. One such 
pathway starts with the activation of PKA (see 2.1.2). 
3.2.2 Treatment model 
The treatment model was made by inhibiting IP3 activation. Active IP3 contributes to 
Ca
2+
 influx, leading to increased calcium concentration in the cell. Cytosolic calcium causes 
apoptosis via increased ER stress (see Model 5), activation of NO synthase (see 2.1.4), and 
activation of Phospholipase A2, which triggers the arachidonic cascade (2.1.4). See Figure 2 for 
comparison of peroxynitrite concentration for untreated disease state versus treatment state with 
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IP3 inhibitors. The effectiveness of existing drugs that inhibit IP3 (including NSAID, XC, and 2-
APB) was mathematically verified in our model. The greatest decrease in apoptotic levels 
occurred when all three of these inhibitors were simultaneously activated without Minocycline. 
3.3 Golgi dysfunction 
3.3.1 Disease model 
The disease state includes the increased activation of all caspases, and caspase-2 
catalyzes the cleavage of Golgin 160 in the Golgi. Inactivation of this protein results in Golgi 
dysfunction, which leads to apoptosis (Jiang et al., 2011). Cleavage of other proteins, such as 
GRASP 65 and p115, also result in golgi dysfunction and apoptosis (see Model 4).  
3.3.2 Treatment model 
IP3 inhibitors alone proved to be effective in decreasing Golgi dysfunction. Inhibition of 
IP3 causes decreased influx of Calcium (see Model 2), which in turn decreases Phospholipase A2 
activation. The arachidonic acid cascade is thus inhibited, decreasing levels of PGE2. This 
inhibits the Fas signaling pathway via inactivation of NF-KappaB (Wajant, 2002). Without Fas 
signaling, caspse-8 levels are lowered. Since caspase-8 is responsible for p115 cleavage (Chiu, 
2002) decreased levels lower Golgi dysfunction.  
Minocycline induced the treatment state by inhibiting cytochrome c translocation to the 
cytosol, therefore inhibiting apoptosome formation and caspase cascade activation (Zhu et al., 
2002). Since caspases 2, 3, and 8 are related to Golgi dysfunction via protein cleavage (see 
2.1.5), their inactivation contributes to lowered Golgi dysfunction.  
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According to our model, while IP3 inhibitors were more effective than Minocycline at 
decreasing Golgi dysfunction, the cocktail of all four drugs was the most effective treatment. 
Refer to Figure 3 for a comparison of Golgi dysfunction levels between the disease state and the 
different treatment states. 
3.4 Endoplasmic reticulum dysfunction 
3.4.1 Disease model 
In the disease state ER dysfunction is caused mainly by ER stress. Many factors 
contribute to increased ER stress, including cytosolic calcium buildup (increased with IP3 
activation – see Model 2) and toxic mSOD1 within the ER. Mutated SOD1 translocates to the 
ER lumen in greater concentrations with excess glutamate present (see 3.6.1 and Model 7) (Soo 
et al., 2012).  
3.4.2 Treatment model 
IP3 inhibitors decreased ER dysfunction while Minocycline alone had no effect. 
Inhibitors of IP3 decrease calcium influx, which decrease caspase-8 activation (see 3.3.2). 
Caspase-8 activates caspase-3 (Slee et al., 1999); therefore its inactivation leads to decreased 
levels of caspase-3. Caspase-3 inactivates EEAT2 receptor and thus increases intracellular 
glutamate (Boston-Howes et al., 2006) (see Model 7), resulting in excitoxicity that leads to toxic 
mSOD1 accumulation in the ER. When caspase-3 is inactivated, this pathway is blocked. 
Minocycline prevents caspase cascade activation (Model 3) and therefore decreases 
caspase-3 activation, leading to decreased glutamate excitotoxicity. While Minocycline alone 
showed no effect mathematically on ER dysfunction when used as a treatment, the cocktail of all 
14 
 
four drugs (Minocycline and the three IP3 inhibitors) showed a slightly greater decreasing effect 
than IP3 inhibitors alone (see Figure 4). 
3.5 Mitochondrial dysfunction 
3.5.1 Disease model 
Mitochondrial dysfunction in the disease state is increased by the presence of active 
caspase-8 and caspase-3. The formation of the apoptosome activates the caspase cascade and 
contributes to mitochondrial dysfunction via caspase-8 and caspase-3 activation. Additionally, 
caspase-8 activation is increased through Fas signaling (see 2.1.9). 
3.5.2 Treatment model 
The treatment model that most greatly decreased mitochondrial dysfunction was created 
by implementing Minocycline alone. Minocycline attenuates the effects of the caspase cascade 
(including mitochondrial dysfunction) by inhibiting cytochrome c release (see Model 3). IP3 
inhibitors seemed to have no effect on levels of mitochondrial dysfunction. Refer to Figure 5 for 
a representation of the different treatment states as they apply to mitochondrial dysfunction. 
3.6 Glutamate excitotoxicity 
3.6.1.1 Disease model 
Glutamate excitoxicity (Model 7) increases with intracellular calcium (see 3.4.2). It 
promotes mSOD1 aggregation and peroxynitrite levels via increased concentrations of 
superoxide anion. Intracellular glutamate induces electron transfer from NADPH to molecular 
oxygen, creating the superoxide anion (Harraz et al., 2008).  
3.6.1.2 Treatment model 
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The treatment state that showed the greatest decrease in glutamate excitotoxicity was 
created by the implementation of both Minocycline and IP3 inhibitors (see Figure 6).  
Minocycline decreases activation of caspases by inhibiting cytochrome c release to the cytosol 
(see 3.5.2 and Model 3). Decreased caspase 3 activation results in decreased cleavage of EEAT 
receptor, allowing for intracellular glutamate to exit the neuron (see Model 7). IP3 inhibitors 
decrease calcium influx, which decreases NF-KappaB activation and Fas signaling (Wajant, 
2002). Absence of Fas signaling results in reduced caspase-3 activation, which is responsible for 
EEAT cleavage (see 3.4.2). Without EEAT cleavage, buildup of intracellular glutamate 
diminishes (see Model 7). IP3 inhibitors alone showed no effect on glutamate excitotoxicity. 
However, the cocktail of both IP3 inhibitors and Minocycline showed a greater mathematical 
decrease in glutamate toxicity than Minocycline alone.  
4. Discussion 
4.1 Disease Model 
Glutamate toxicity increases with calcium influx and caspase activation, resulting in toxic 
mSOD1 buildup in the ER lumen which then enters the ER. The ER stress that results from the 
increase of cytosolic calcium concentration then leads to aggregation of mSOD1 in the ER. 
Mutated SOD1 then activates CHOP protein in the ER, which, together with Bim, catalyzes the 
translocation of phosphorylated Bax to the mitochondria.  
Mitochondrial Bax then gives rise to MAC Channel formation, catalyzing the exiting of 
cytochrome c from the mitochondria into the cytosol. The translocation of phosphorylated Bax to 
the mitochondria also contributes to cytochrome c exiting the mitochondria by forming the MAC 
channel. In the cytosol, cytochrome c joins with Apaf 1 to form the apoptosome, which then 
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triggers the caspase cascade (and further promoting glutamate toxicity) via activation of caspase-
9. Increased cytosolic calcium concentration contributes to this process by facilitating the 
buildup of ER stress. The increased ER stress relative to that of the Golgi and mitochondria is 
worth noting for future studies. It also suggests that treatments focused on directly inhibiting ER 
stress buildup may be more effective than treatments inhibiting processes that induce stress to 
other organelles.  
Increased cytosolic calcium also causes activation of nitric oxide synthase, which then 
synthesizes nitric oxide. Nitric oxide then combines with the superoxide anion from the 
lysosome to create peroxynitrite, which activates PKA. PKA, together with PGE2 (a product of 
the arachidonic cascade), activates NF-KappaB. This leads to Fas signaling, resulting in caspase 
activation and apoptosis.  
The role the Golgi apparatus plays in apoptosis is especially noteworthy because that role 
is lacking detailed discussion in the literature on ALS. The Golgi dysfunction occurs as a result 
of many apoptotic factors, including apoptosome formation. The apoptosome that forms in 
response to processes set in motion by mSOD1 aggregation triggers the caspase cascade, which 
leads to cleavage and activation of procaspase-2. Caspase-2 then catalyzes the cleavage and 
inactivation of Golgi 160, which resides in the Golgi. The activation of caspase-2 is a critical part 
of this process because it cleaves the Golgin 160 protein at a unique
 
site that cannot be cleaved 
by other caspases, even those with very similar structure to caspase-2. Cleavage at this site
 
triggers more cleavage by other caspases at other sites (Mancini et al., 2000). When Golgi 160 is 
inactivated, Golgi dysfunction results and leads to neuronal apoptosis. This occurs with cleavage 
of other golgi proteins (e.g. p115) as well. Cleavage of such proteins is enhanced by caspases. 
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4.2 Treatment Model 
Of the existing drugs included in this model, Minocycline and IP3 inhibitors were 
mathematically verified to be effective in decreasing apoptotic levels. This supports previous 
findings from research on these drugs. 
When a cocktail of both Minocycline and IP3 inhibitors was implemented, apoptotic 
levels dramatically decreased. Limiting the cytosolic calcium concentration (via IP3 inhibitors) in 
the treatment model dramatically decreased Fas signaling, thus reducing caspase activation and 
glutamate toxicity. Peroxynitrite levels were also lowered due to reduced activation of NO 
synthase. The decrease in both glutamate toxicity and calcium influx led to lower levels of ER 
stress and therefore reduced ER dysfunction.  
Inhibition of cytochrome c release by Minocycline lowered caspase activation. Inactivation 
of caspase-3 and caspase-8 reduced mitochondrial dysfunction. Without activation of caspase-2, 
Golgi 160 inactivation decreased. Likewise, reduced activation of caspase-3 and caspase-8 led to 
decreased cleavage of both p115 and GRASP65. As a result, Golgi dysfunction leading to 
apoptosis was suppressed. Further research on this aspect of the model could be beneficial in 
potentially finding novel drugs that inhibit pathways involved in ALS onset. 
Different aspects of the model – organelle dysfunction, peroxynitrite levels, and glutamate 
excitotoxicity – varied mathematically in their apparent responses to the different treatment 
combinations. However, overall apoptotic levels decreased more significantly in the presence of 
all four drugs in comparison to Minocycline or IP3 inhibitors alone. 
5. Conclusion 
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The model created and evaluated using BST illustrates various key biochemical processes 
that contribute to familial ALS onset caused by pathways set forth by SOD1 gene mutation. 
These key processes include mSOD1 aggregation in the cytosol and the organelles, formation of 
reactive oxygen and nitrogen species and their toxic effects on the neuron, organelle dysfunction, 
glutamate excitotoxicity, caspase cascade activation, and Ca
2+
 accumulation in the cytosol of the 
neuron. In addition to exploring the effects of these and other reactions that occur within a 
neuron affected by ALS, various existing treatments were tested mathematically to evaluate their 
ability to decrease levels of apoptosis and apoptotic factors. These treatments were also 
combined to evaluate their combined effect on apoptotic levels. This ALS model suggests that an 
effective treatment would be a cocktail of Minocycline and IP3 inhibitors (XC, 2-ABP, and 
NSAID). It would be beneficial to research the effect of this cocktail in animal models. This 
model can theoretically be used to assess the effect of an innovative drug (or cocktail of existing 
drugs) that acts on any reaction within the model before it undergoes more expensive laboratory 
tests.  
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Model 1 Mutated SOD1 aggregation leading to cytochrome c release from mitochondria via 
CHOP activation 
Mutated SOD1 activates CHOP, which catalyzes the translocation of phosphorylated Bax to the 
mitochondria. This allows for MAC Channel formation, which promotes translocation of 
cytochrome c from the mitochondria to the cytosol. Once in the cytosol, cytochrome c is free to 
form the apoptosome complex with Apaf 1, which triggers the caspase cascade via activation of 
caspase-9. 
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Model 2 Effects of Ca
2
 and reactive nitrogen species 
The accumulation of Ca
2+
 in the cytosol catalyzes both the activation of NO synthase and the 
start of the arachidonic acid cascade, producing PGE2. PGE2 contributes to further Ca
2+
 
accumulation. NO synthase creates nitric oxide, which leads to peroxynitrite synthesis. Both 
calcium and peroxynitrite contribute to activation of PKA. Active PKA catalyzes the activation 
of NF-KappaB, which initiates Fas signaling via transcription of Fas ligand. Ca
2+ 
influx is 
enhanced by active IP3, which is inhibited by the drugs shown. 
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Model 3 Apoptosome formation and caspase activation 
 Formation of the apoptosome forms when cytochrome c exits the mitochondria into the cytosol. 
The apoptosome activates caspase 9, which triggers the caspase cascade. One effect of caspase 
activation is Cox-2 transcription, initiated by caspase 1. This activates the arachidonic acid 
cascade, resulting in calcium influx. 
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Model 4 Golgi dysfunction 
Golgi dysfunction occurs when golgi proteins become cleaved and do not perform their normal 
function within the golgi. These proteins include Golgin 160 GRASP 65, and p115 – all of which 
are cleaved by caspases. Complexes formed by normally functioning proteins act to suppress 
golgi dysfunction. Cleaved products induce dysfunction.  
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Model 5 Endoplasmic Reticulum dysfunction 
Dysfunction in the ER occurs with mSOD1 aggregation leading to NHK buildup. Accumulation 
of cytosolic Ca2+ promotes ER stress and dysfunction. Bcl-xL acts as an antiapoptotic factor, 
inhibiting stress to the ER, while Bim ER increases stress. 
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Model 6 Mitochondrial dysfunction 
Mitochondrial dysfunction is enhanced with caspase-3 and caspase-8 activation. Mutated SOD1, 
which promotes cytochrome c release, can be tied back to caspase activation (which increases 
mitochondrial dysfunction) via activation of CHOP. Additionally, calcium buildup within the 
mitochondria contributes to organelle dysfunction. Anti-apoptotic factors Bcl 2 and Bcl-xL 
inhibit dysfunction of the mitochondria.  
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Model 7 Glutamate excitotoxicity  
Intracellular glutamate is increased with inactivation of EEAT2, which is cleaved by caspase-3. 
Glutamate toxicity leads to increased mSOD1 aggregation, which produces ER stress and 
dysfunction. Glutamate promotes electron transfer from NADPH to oxygen, creating the 
superoxide anion. This increases levels of reactive nitrogen species. Cytochrome c release is 
increased with glutamate toxicity as well.  
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Figure 1: Apoptosis 
Apoptotic levels showed the greatest decrease in the treatment state that used both IP3 inhibitors 
and Minocycline. The decrease in apoptotic levels was 1.5 times greater than the decrease 
observed with Minocycline alone.  
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Figure 2: Peroxynitrite 
Peroxynitrite levels showed the greatest decrease from disease to treatment state with 
Minocycline alone. The decrease with the cocktail drug was about half of that with Minocycline. 
IP3 inhibitors showed a very small decrease in comparison to the cocktail drug and Minocycline.  
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Figure 3: Golgi dysfunction 
Golgi dysfunction was decreased with all three treatment states. The most effective treatment 
state was induced by the use of both IP3 inhibitors and Minocycline. 
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Figure 4: Endoplasmic reticulum dysfunction 
ER dysfunction was decreased the most with the use of the both IP3 inhibitors and Minocycline. 
IP3 inhibitors showed no decreasing effect when implemented without Minocycline. While 
Minocycline alone was effective at decreasing ER dysfunction, the cocktail drug was twenty-five 
percent more effective.  
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Figure 5: Mitochondrial dysfunction 
Minocycline had the greatest decreasing effect on mitochondrial dysfunction in the treatment 
state. IP3 inhibitors showed no effect, while the cocktail drug showed a smaller decrease than 
that of Minocycline. 
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Figure 6: Glutamate excitotoxicity 
The use of both IP3 inhibitors and Minocycline showed the greatest decrease in intracellular 
glutamate from disease to treatment state. IP3 inhibitors showed no decreasing effect when used 
alone. Minocycline decreased intracellular glutamate by more than twenty-five percent, while the 
cocktail drug decreased it by more than thirty percent. 
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